The authors indicate that the study suggests that the inhibition of IL-15 is a viable strategy in the treatment of CD and point to the need for further studies on non-responsive to gluten-free diet CD (Lähdeaho et al., 2019). This evidence concerns the gene IL15 and Cowden disease.